PRP & Exosomes

PRP injection for tennis elbow shows mixed evidence across clinical trials

Clinical trials report varied findings when comparing platelet-rich plasma with steroid shots for lateral epicondylitis.

The clinical evidence evaluating a PRP injection for tennis elbow is mixed rather than settled. Tennis elbow carries the formal medical name lateral epicondylitis, marking tenderness where forearm tendons attach to the bone on the outer elbow.

This guide outlines what pooled clinical trials report when comparing platelet-rich plasma to cortisone shots, why published studies reach conflicting verdicts, and what clinics charge for treatment.

What the Evidence Shows

A PRP injection for tennis elbow delivers mixed clinical results across randomized trials rather than a definitive answer. Tennis elbow, or lateral epicondylitis, involves painful irritation where forearm tendons attach to the outer elbow bone. The American Academy of Orthopaedic Surgeons (AAOS) states that approximately 80 to 95 percent of patients achieve success with nonsurgical management. When standard options like rest, activity modification, forearm bracing, and physical therapy leave pain unresolved, patients often consider regenerative procedures.

Clinical research evaluating platelet-rich plasma (PRP) presents an uneven picture across different trials. The American Academy of Orthopaedic Surgeons notes that while some studies regarding the effectiveness of PRP remain inconclusive, other investigations report promising results. PRP is not FDA-approved for tendon use, leaving clinicians and patients to weigh contrasting academic reports.

Pooled trial data provide additional nuance when researchers measure outcomes over different time windows. A network meta-analysis reviewing 10 randomized controlled trials with roughly 500 or more patients evaluated PRP, autologous whole-blood injections, and steroid injections. In that analysis, PRP showed lower pain scores than steroid injections at the final patient follow-up. Both PRP and autologous blood improved arm disability scores compared with steroid shots. The review found that autologous blood carried a higher complication rate than steroids, while PRP and steroids demonstrated similar overall safety. The authors emphasized significant caveats: each comparison included few studies, clinical designs and follow-up intervals varied widely, and no single intervention emerged as a clear winner across every measured outcome.

A separate meta-analysis synthesizing 8 randomized trials with 511 patients compared PRP directly with steroid shots for lateral epicondylitis. The researchers identified no significant difference in short-term pain relief between the two injections. Steroid injections proved more effective for arm function during the initial window spanning 2 to 4 weeks and 6 to 8 weeks. Platelet-rich plasma demonstrated lower pain scores at 6 months and 1 year, alongside better functional scores at intermediate and long-term follow-up intervals.

PRP vs Cortisone for Tennis Elbow

Patients weighing a PRP injection for tennis elbow are frequently choosing between an autologous biologic and a traditional cortisone shot. Corticosteroids provide fast anti-inflammatory activity, whereas platelet-rich plasma trials report slower initial changes with longer-lasting follow-up markers.

Evaluation MetricCortisone (Steroid) ShotPRP Injection
Short-term pain reliefNo significant difference from PRP in pooled trialsNo significant difference from steroid in pooled trials
Short-term arm functionHigher functional scores at 2 to 8 weeksSlower functional improvement initially
Pain at 6 to 12 monthsHigher pain scores reported vs PRPLower pain scores reported vs steroid
Safety profileAAOS advises sparing use because excess can weaken the attachmentSimilar safety to steroid in the network meta-analysis
FDA statusApproved anti-inflammatory drugNot approved for tennis elbow
Typical patient costNot covered in this guide’s data; ask your plan$400 to $2,000 per session out of pocket

The timing of symptom relief remains the primary clinical contrast between these two options. The American Academy of Orthopaedic Surgeons notes that while steroids serve as very effective anti-inflammatory medicines, steroid injections should be used very sparingly for lateral epicondylitis because excessive use can weaken the lateral epicondyle tendon attachment. Patients interested in how these therapies perform across other joints can review our broader guide on PRP vs cortisone.

This is not a route to a guaranteed outcome, and no trial summarized here promises one. Patients early in their symptoms should weigh first-line conservative care before paying cash. Our assessment would change if larger trials reported consistent results across preparations, or if a PRP product received formal FDA approval for tendon treatment.

Why the Trials Disagree

Published medical literature on PRP for tennis elbow contains conflicting conclusions because clinical protocols vary between trial centers. A systematic review published in 2014 reported strong evidence against PRP injections for chronic lateral epicondylar tendinopathy. Later pooled analyses reported lower pain scores with PRP at six months and one year.

Study methods and biologic formulations explain much of this divergence. A 2025 meta-analysis found that published trials vary widely in reported clinical outcomes, with platelet concentration proposed as one key explanation for the differing results. Commercial processing systems yield differing cellular mixtures:

  • Platelet concentrations: Centrifuge protocols produce varying baseline concentrations of platelets above whole-blood levels.
  • White blood cell presence: Preparations are categorized as leukocyte-rich or leukocyte-poor, altering the cellular composition delivered to the tissue.
  • Preparation systems: Different commercial kits and clinic protocols produce different mixtures, so ask which one is used.

Because preparation techniques differ substantially from one clinic to another, outcomes documented in a specific clinical trial cannot be assumed to apply to every private clinic’s proprietary mixture. Furthermore, the Food and Drug Administration has not granted approval for any PRP product targeting tennis elbow or other tendon indications. The agency outlines these regulatory boundaries in its consumer alert on regenerative medicine.

What a PRP Course Costs and Who Pays

Patients receiving platelet-rich plasma must plan to pay clinic fees directly. On Medical Frontier, our documented self-pay pricing for a PRP injection cost spans from $400 to $2,000 for a single treatment session. When an orthopedic physician recommends a multi-injection protocol consisting of two to four visits, total package costs range from $1,500 to $6,000.

Health insurance plans almost never provide reimbursement for platelet-rich plasma administered for lateral epicondylitis. Our insurance guide covers how plans treat PRP. Even when a clinic submits billing paperwork using Category III tracking codes, as explained in our review of PRP CPT code 0232T, insurers routinely issue formal claim denials. You can read more about payer criteria in our guide detailing whether insurance covers PRP.

What Happens at the Appointment

A PRP procedure takes place in an outpatient clinic and relies entirely on your own blood. A clinical assistant draws a blood sample from your arm using a standard collection tube. The staff places that sample into an office centrifuge, spinning the tube to isolate the concentrated platelet layer from red blood cells.

Once the preparation is processed, the clinician injects the platelet-rich solution directly near the affected tendon on your outer elbow. The injection does not involve foreign donor tissue or synthetic pharmaceuticals. Injection-site soreness represents the primary side effect reported following treatment. You can review common post-procedure considerations in our overview of PRP injection recovery and side effects.

Questions to Ask Before Booking

Before committing funds to an elective biologic procedure, evaluate the provider’s protocol and billing structure. Learning how to vet a clinic protects you from aggressive sales tactics and unexpected bills.

  • What specific centrifuge system and platelet concentration does your practice use?
  • Is your injected preparation leukocyte-rich or leukocyte-poor?
  • What is the total written cost for the full treatment course, including post-injection follow-up visits?
  • Which validated clinical outcome measures do you monitor to track patient progress?
  • Which nonsurgical therapies, such as rest, activity modifications, counterforce bracing, or physical therapy, should I complete first?

Insist on receiving all financial agreements in writing before agreeing to an elbow injection. Transparent practices provide itemized self-pay schedules and discuss conservative alternatives openly.

Considering a PRP Injection for Tennis Elbow

The clinical evidence for platelet-rich plasma in lateral epicondylitis remains mixed rather than definitively proven. Steroid injections demonstrate faster functional improvement in early weeks, whereas PRP studies report lower pain scores after six months. However, the Food and Drug Administration has not approved PRP for tendon conditions, trial findings vary widely, and private insurance policies consistently exclude the procedure.

If you are weighing an injection for chronic outer-elbow pain, evaluate conservative non-interventional options before paying cash. Compare procedural timelines in our guide on PRP vs cortisone, verify out-of-pocket estimates using our cost estimator, and request a complete written cost breakdown from your orthopedist before scheduling a PRP injection for tennis elbow.

Frequently asked questions

Does a PRP injection help tennis elbow?

The clinical evidence remains mixed rather than settled. The American Academy of Orthopaedic Surgeons notes that while some studies show promising results, other trials remain inconclusive. Pooled research suggests platelet-rich plasma may hold up better than cortisone past six months, but preparations vary and the procedure lacks regulatory clearance.

Is PRP better than a cortisone shot for tennis elbow?

Meta-analyses report that steroid shots provide faster improvements in pain and arm function within the first two months. Studies tracking patients at six months and one year report lower pain scores with platelet-rich plasma. For a broader comparison across other joints, review our PRP vs cortisone guide.

Is PRP for tennis elbow FDA approved?

No, the Food and Drug Administration (FDA) has not approved any platelet-rich plasma biologic product for tennis elbow or other tendon uses. The agency monitors unapproved regenerative therapies as detailed in its consumer alert on regenerative medicine. You can read more about regulatory standards in our FDA status overview.

How much does a PRP injection for tennis elbow cost?

A single platelet-rich plasma session typically costs between $400 and $2,000 out of pocket. A multi-injection series of two to four visits ranges from $1,500 to $6,000. You can inspect complete pricing variables in our PRP injection cost guide.

Does insurance cover PRP for tennis elbow?

Insurance rarely pays for platelet-rich plasma used on tendons such as the outer elbow. Learn more about billing policies in our guides on insurance coverage for PRP and PRP CPT code 0232T.

What are the side effects of a PRP injection in the elbow?

Injection-site soreness is the most common side effect reported after the procedure. Review our dedicated guide on PRP injection recovery and side effects for additional details.

Medical disclaimer. Medical Frontier is an independent educational resource. This page is for general information only and is not medical advice, diagnosis, or treatment, and does not create a doctor–patient relationship. Most regenerative therapies discussed here are not FDA-approved for the uses described and may be offered under limited exemptions or in clinical trials only. Always consult a licensed physician before making any treatment decision.